loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: Zafirlukast

    Menu

    Zafirlukast

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 14,878Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20547 / DOSAGE - TABLET;ORAL - 10MG

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    ZAFIRLUKAST(UNII: XZ629S5L50)
    (ZAFIRLUKAST - UNII:XZ629S5L50)     		ZAFIRLUKAST20mg | 10mg

    Inactive Ingredients

    Ingredient Name
    Avera McKennan Hospital
    AvPAK
    Par Pharmaceutical Inc.
    AstraZeneca Pharmaceuticals LP
    Major Pharmaceuticals
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)  
    CROSCARMELLOSE SODIUM(M28OL1HH48) 
    HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)    
    HYPROMELLOSE 2910 (5 MPA.S)(R75537T0T4)    
    HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)    
    HYPROMELLOSES(3NXW29V3WO)  
    LACTOSE MONOHYDRATE(EWQ57Q8I5X)  
    LACTOSE(J2B2A4N98G)    
    LACTOSE, UNSPECIFIED FORM(J2B2A4N98G)   
    MAGNESIUM STEARATE(70097M6I30)
    MICROCRYSTALLINE CELLULOSE(OP1R32D61U)    
    POLYETHYLENE GLYCOL 400(B697894SGQ)    
    POVIDONE, UNSPECIFIED(FZ989GH94E)    
    POVIDONES(FZ989GH94E)  
    SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)    
    TITANIUM DIOXIDE(15FIX9V2JP)